 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 January 1994 | Volume 120 Issue 1 | Pages 12-17
Objective: To examine possible risk factors for relapse, including chronic nasal carriage of Staphylococcus aureus and serial antineutrophil cytoplasmic antibody (ANCA) determinations in patients with Wegener granulomatosis.
Design: Observational cohort study.
Setting: Outpatient clinic at a university-affiliated hospital.
Patients: Consecutive patients (n = 71) with biopsy-proven Wegener granulomatosis who were seen during follow-up at the outpatient clinic from January 1988 to July 1991. Fourteen patients were ineligible or dropped out; 57 patients were analyzed.
Measurements: Serial ANCA determinations and swab cultures of both anterior nares for S. aureus taken at each visit every 4 to 6 weeks. Occurrence of infections and relapses of Wegener granulomatosis were identified according to strict, predefined criteria.
Results: Thirty-six of the 57 patients (63%; 95% CI, 49% to 76%) were found to be chronic nasal carriers of S. aureus (
Conclusion: Chronic nasal carriage of S. aureus identifies a subgroup of patients with Wegener granulomatosis who are more prone to relapses of the disease, suggesting a role for S. aureus in its pathophysiology and a possible clue for treatment.
Author and Article Information
From University Hospital Groningen, the Netherlands.
ARTICLE
Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis
75% of nasal cultures positive for S. aureus). Proportional-hazards regression analysis identified chronic nasal carriage of S. aureus (adjusted relative risk, 7.16; CI, 1.63 to 31.50), creatinine clearance above 60 mL x min–1 (adjusted relative risk, 2.94; CI, 1.27 to 6.67), and a history of previous relapses of Wegener granulomatosis (adjusted relative risk, 1.33; CI, 0.98 to 1.78) as independent risk factors for relapse. Twenty-two of 33 patients persistently or intermittently positive for ANCA had a relapse as opposed to only 1 of 21 persistently negative patients. Relapses of Wegener granulomatosis were not related to diagnosed infections.
Requests for Reprints: Coen A. Stegeman, MD, Department of Internal Medicine, Division of Nephrology, State University Hospital, Ooster-singel 59, 9713 EZ, Groningen, the Netherlands.
Acknowledgment: The authors thank Dr. J. Hermans, PhD, for statistical advice.
Grant Support: By grant 89.0872 from the Dutch Kidney Foundation.
This article has been cited by other articles:
|
|
 |
|
  C Mukhtyar, O Flossmann, B Hellmich, P Bacon, M Cid, J W Cohen-Tervaert, W L Gross, L Guillevin, D Jayne, A Mahr, et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force Ann Rheum Dis, July 1, 2008; 67(7): 1004 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Thewissen and J. W. Cohen Tervaert Leptin and ANCA-associated vasculitis: a healthy link? Rheumatology, April 1, 2008; 47(4): 387 - 389. [Full Text] [PDF]
|
|
|
|
 |
|
 R. A.F. de Lind van Wijngaarden, L. van Rijn, E. C. Hagen, R. A. Watts, G. Gregorini, J. W. C. Tervaert, A. D. Mahr, J. L. Niles, E. de Heer, J. A. Bruijn, et al. Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis: The Cause Is Hidden, but the Result Is Known Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 237 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lionaki, S. L. Hogan, R. J. Falk, M. S. Joy, H. Chin, C. E. Jennette, J. C. Jennette, and P. H. Nachman Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case control study Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3508 - 3515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jayne Leflunomide versus methotrexate in Wegener's granulomatosis Rheumatology, July 1, 2007; 46(7): 1047 - 1048. [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Brown, H. R. Lock, T. G.A.M. Wolfs, W. A. Buurman, S. H. Sacks, and M. G. Robson Toll-Like Receptor 4 Ligation on Intrinsic Renal Cells Contributes to the Induction of Antibody-Mediated Glomerulonephritis via CXCL1 and CXCL2 J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1732 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Popa, C. A. Stegeman, W. H. Abdulahad, B. van der Meer, J. Arends, W. M. Manson, N. A. Bos, C. G. M. Kallenberg, and J.-W. Cohen Tervaert Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis Rheumatology, June 1, 2007; 46(6): 1029 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stewart, D. Cohen, I. Bhattacharyya, L. Scheitler, S. Riley, K. Calamia, C. Migliorati, R. Baughman, P. Langford, and J. Katz Oral manifestations of Wegener's granulomatosis: A report of three cases and a literature review J Am Dent Assoc, March 1, 2007; 138(3): 338 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Hogan, G. S. Cooper, D. A. Savitz, L. A. Nylander-French, C. G. Parks, H. Chin, C. E. Jennette, S. Lionaki, J. C. Jennette, and R. J. Falk Association of Silica Exposure with Anti-Neutrophil Cytoplasmic Autoantibody Small-Vessel Vasculitis: A Population-Based, Case-Control Study Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 290 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chan, V. d'Intini, and J. Savige Anti-neutrophil cytoplasmic antibody (ANCA)-associated microscopic polyangiitis following a suppurative wound infection Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2993 - 2994. [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Brown, H. R. Lock, S. H. Sacks, and M. G. Robson TLR2 Stimulation of Intrinsic Renal Cells in the Induction of Immune-Mediated Glomerulonephritis J. Immunol., August 1, 2006; 177(3): 1925 - 1931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kallenberg, C. Stegeman, H Bootsma, M Bijl, and P. Limburg Quantitation of Autoantibodies in Systemic Autoimmune Diseases: Clinically Useful? Lupus, July 1, 2006; 15(7): 397 - 402. [Abstract] [PDF]
|
|
|
|
|
|
H. J. Brown, S. H. Sacks, and M. G. Robson Toll-Like Receptor 2 Agonists Exacerbate Accelerated Nephrotoxic Nephritis J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1931 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Jennette, H. Xiao, and R. J. Falk Pathogenesis of Vascular Inflammation by Anti-Neutrophil Cytoplasmic Antibodies J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1235 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Thickett, A. G. Richter, N. Nathani, G. D. Perkins, and L. Harper Pulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis Rheumatology, March 1, 2006; 45(3): 261 - 268. [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Frankel, G. P. Cosgrove, A. Fischer, R. T. Meehan, and K. K. Brown Update in the diagnosis and management of pulmonary vasculitis. Chest, February 1, 2006; 129(2): 452 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Brown Pulmonary vasculitis. Proceedings of the ATS, January 1, 2006; 3(1): 48 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Hogan, R. J. Falk, H. Chin, J. Cai, C. E. Jennette, J. C. Jennette, and P. H. Nachman Predictors of Relapse and Treatment Resistance in Antineutrophil Cytoplasmic Antibody-Associated Small-Vessel Vasculitis Ann Intern Med, November 1, 2005; 143(9): 621 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S K Frankel, G P Cosgrove, and K K Brown Small vessel vasculitis of the lung Chronic Respiratory Disease, April 1, 2005; 2(2): 75 - 84. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Pfister, M. Ollert, L. F. Frohlich, L. Quintanilla-Martinez, T. V. Colby, U. Specks, and D. E. Jenne Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo Blood, September 1, 2004; 104(5): 1411 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jayne, N. Rasmussen, K. Andrassy, P. Bacon, J. W. C. Tervaert, J. Dadoniene, A. Ekstrand, G. Gaskin, G. Gregorini, K. de Groot, et al. A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies N. Engl. J. Med., July 3, 2003; 349(1): 36 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Rarok, P. C. Limburg, and C. G. M. Kallenberg Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies J. Leukoc. Biol., July 1, 2003; 74(1): 3 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Stegeman Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2077 - 2080. [Full Text] [PDF]
|
|
|
|
|
|
G. F. Ferraccioli, R. Assaloni, E. Di Poi, E. Gremese, G. De Marchi, and M. Fabris Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial Rheumatology, October 1, 2002; 41(10): 1109 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Falk and J. C. Jennette ANCA Are Pathogenic--Oh Yes They Are! J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1977 - 1979. [Full Text] [PDF]
|
|
|
|
|
|
G Ferraccioli, F Mecchia, E Di Poi, and M Fabris Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections Ann Rheum Dis, April 1, 2002; 61(4): 358 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Inoue, Y. Kawahito, H. Sano, T. Yoshikawa, M. Toyoshima, K. Chida, T. Suda, S. Imokawa, and H. Nakamura Antituberculous Drugs for Wegener's Granulomatosis Chest, December 1, 2001; 120(6): 2112 - 2113. [Full Text] [PDF]
|
|
|
|
|
|
M. Toyoshima, K. Chida, T. Suda, S. Imokawa, and H. Nakamura Wegener's Granulomatosis Responding to Antituberculous Drugs Chest, February 1, 2001; 119(2): 643 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Jethwa, S. H. Clarke, Y. Itoh-Lindstrom, R. J. Falk, J. C. Jennette, and P. H. Nachman Restriction in V{kappa} Gene Use and Antigen Selection in Anti-Myeloperoxidase Response in Mice J. Immunol., October 1, 2000; 165(7): 3890 - 3897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.R.W. Jayne, H. Chapel, D. Adu, S. Misbah, D. O'Donoghue, D. Scott, and C.M. Lockwood Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity QJM, July 1, 2000; 93(7): 433 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jayne Evidence-based treatment of systemic vasculitis Rheumatology, June 1, 2000; 39(6): 585 - 595. [Full Text] [PDF]
|
|
|
|
|
|
C. Roozendaal, K. Pogany, E.J. Hummel, G. Horst, G. Dijkstra, G.F. Nelis, P.C. Limburg, J.H. Kleibeuker, and C.G.M. Kallenberg Titres of anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity QJM, November 1, 1999; 92(11): 651 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C M. Kobold, C. G M Kallenberg, and J. W. C. Tervaert Monocyte activation in patients with Wegener's granulomatosis Ann Rheum Dis, April 1, 1999; 58(4): 237 - 245. [Abstract] [Full Text]
|
|
|
|
|
|
K de Groot and W L Gross Wegener's granulomatosis: disease course, assessment of activity and extent and treatment Lupus, May 1, 1998; 7(4): 285 - 291. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Burns Pulmonary vasculitis Thorax, March 1, 1998; 53(3): 220 - 227. [Full Text]
|
|
|
|
|
|
J. C. Jennette and R. J. Falk Small-Vessel Vasculitis N. Engl. J. Med., November 20, 1997; 337(21): 1512 - 1523. [Full Text] [PDF]
|
|
|
|
|
|
C. A. Stegeman, J. W. Cohen Tervaert, P. E. de Jong, C. G.M. Kallenberg, and The Dutch Co-trimoxazole Wegener Study Group Trimethoprim-Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's Granulomatosis N. Engl. J. Med., July 4, 1996; 335(1): 16 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. DeRemee Empiricism and Wegener's Granulomatosis N. Engl. J. Med., July 4, 1996; 335(1): 54 - 55. [Full Text]
|
|
Article
